Effectiveness of GLP-1 medications for treating type 2 diabetes in young people
Real-world Effectiveness and Utilization of Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Type 2 Diabetes in Adolescents and Young Adults
This study looks at how well a type of diabetes medication called GLP-1 receptor agonists works for teenagers and young adults with type 2 diabetes, while also exploring the challenges they face in getting the treatment they need.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10825007 on NIH RePORTER |
What this research studies
This research investigates how effective glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are for managing type 2 diabetes in adolescents and young adults. It aims to understand their real-world usage compared to other diabetes treatments, particularly focusing on the challenges faced by young patients, including access issues and health disparities. By analyzing data from a large electronic health record database, the study will provide insights into how these medications perform in everyday clinical settings for younger populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults aged 17 to 40 who are diagnosed with type 2 diabetes.
Not a fit: Patients who are not diagnosed with type 2 diabetes or are older than 40 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could improve treatment options and outcomes for young people with type 2 diabetes.
How similar studies have performed: Previous research has shown promising results with GLP-1 RAs in adult populations, but this specific focus on adolescents and young adults is relatively novel.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Chu, Patricia Yea — Children's Hosp of Philadelphia
- Study coordinator: Chu, Patricia Yea
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.